An evaluation of the Caribbean regulatory system centralized assessment process for medicines submitted 2017–2018 using the OpERA methodology

Figures & data

Table 1 Milestones and product characteristics collected through the OpERA program

Fig. 1 Flow chart of the regulatory assessment process employed by the CRS centralized procedure

Fig. 2 Comparison of key activities for 2017 and 2018 (medians with 25th–75th percentiles)